Roche Navigation Menu RocheNet : RocheNet
  • Contactos
  • Entrar
  • Logout
  • Pesquisa
Roche
  • Topo
  • Homepage
  • Search
  • Close search

						
							

Searching

    • Homepage
    • Medicamentos
      Medicamentos
      • Bases de Dados de Medicamentos
      • Infomed
      • Prontuário Terapêutico
    • Especialidades
      Especialidades
      • Oncologia
      • Eventos
      • Guidelines
      • Revistas
      • Sites
      • Pneumologia
      • Eventos
      • Guidelines
      • Revistas
      • Sites
      • Neurologia
      • Eventos
      • Guidelines
      • Revistas
      • Sites
      • Hemofilia
      • Eventos
      • Guidelines
      • Revistas
      • Sites
      • Reumatologia
      • Eventos
      • Guidelines
      • Revistas
      • Sites
      • Hematologia
      • Eventos
      • Guidelines
      • Revistas
      • Sites
      • Oftalmologia
      Em destaque Oncologia

    • Publicações
      Publicações
      • Bases de Dados
      • PubMed
      • Revistas Free Full Text
      • Bibliotecas Nacionais
      • Medicamentos
      • Infomed
      • Prontuário Terapêutico
      • Guidelines
      • Hematologia
      • Neurologia
      • Oncologia
      • Pneumologia
      • Reumatologia
      Em destaque Revistas Free Full Text

    • Recursos Online
      Recursos Online
      • Sites e Apps Roche
      • Artrite Reumatóide
      • InfoCancro
      • Linfoma
      • Sites Nacionais
      • Associações Profissionais
      • Associações de Doentes
      • Hospitais e Serviços Hospitalares
      • Instituições
      • Portais e outros sites saúde
      • Publicações
      • Serviços Saúde
      • Sociedades e Ordens
      • Universidades e Ensino
      • Sites por Especialidade
      • Hematologia
      • Neurologia
      • Oncologia
      • Pneumologia
      • Reumatologia
      Em destaque Sites Roche

    • Agenda de Eventos
      Agenda de Eventos
      • Eventos de 2022
      • Sugerir Eventos
      • Oncologia
      • Hematologia
      • Pneumologia
      • Hemofilia
      • Reumatologia
      • Neurologia
      Em destaque Próximos Eventos

    • Oftalmologia
      Oftalmologia
    • Homepage
    • Medicamentos
      • Bases de Dados de Medicamentos
        • Infomed
        • Prontuário Terapêutico
    • Especialidades
      • Oncologia
        • Eventos
        • Guidelines
        • Revistas
        • Sites
      • Pneumologia
        • Eventos
        • Guidelines
        • Revistas
        • Sites
      • Neurologia
        • Eventos
        • Guidelines
        • Revistas
        • Sites
      • Hemofilia
        • Eventos
        • Guidelines
        • Revistas
        • Sites
      • Reumatologia
        • Eventos
        • Guidelines
        • Revistas
        • Sites
      • Hematologia
        • Eventos
        • Guidelines
        • Revistas
        • Sites
      • Oftalmologia
    • Publicações
      • Bases de Dados
        • PubMed
      • Revistas Free Full Text
      • Bibliotecas Nacionais
      • Medicamentos
        • Infomed
        • Prontuário Terapêutico
      • Guidelines
        • Hematologia
        • Neurologia
        • Oncologia
        • Pneumologia
        • Reumatologia
    • Recursos Online
      • Sites e Apps Roche
        • Artrite Reumatóide
        • InfoCancro
        • Linfoma
      • Sites Nacionais
        • Associações Profissionais
        • Associações de Doentes
        • Hospitais e Serviços Hospitalares
        • Instituições
        • Portais e outros sites saúde
        • Publicações
        • Serviços Saúde
        • Sociedades e Ordens
        • Universidades e Ensino
      • Sites por Especialidade
        • Hematologia
        • Neurologia
        • Oncologia
        • Pneumologia
        • Reumatologia
    • Agenda de Eventos
      • Eventos de 2022
      • Sugerir Eventos
      • Oncologia
      • Hematologia
      • Pneumologia
      • Hemofilia
      • Reumatologia
      • Neurologia
    • Oftalmologia
    • Contactos
    • Entrar
    • Logout
    Fechar

    1 - of Resultado(s) para ""

    No results

    • POSTERS

      Saiba mais

    • Booklet ASH 2020
    • SPOTLIGHT SESSION
    • POSTERS
    • HAVEN 1-4
    • Mais
      • SPOTLIGHT SESSION
      • POSTERS
      • HAVEN 1-4

    147 Effect of Moderate and Severe Hemophilia a on Daily Life in Children and Their Caregivers: A CHESS Paediatrics Study Analysis



    AUTORES Kate Khair, PhD1,2; Francis Nissen3; Mariabeth Silkey3; Tom Burke2; Aijing Shang, MD, PhD3; Martynas Aizenas3; Oliver Meier3; Jamie O’Hara, MSc2,4; Declan Noone, MSc2.

    1Haemnet, London, United Kingdom; 2HCD Economics, Daresbury, United Kingdom; 3F. Hoffmann-La Roche Ltd, Basel, Switzerland; 4University of Chester, Chester, United Kingdom.

    Aceda ao Abstract
    Online Session

    510 Hemophilia Natural History Study (ATHN 7): Baseline Characteristics, Adverse Events, and Self-Reported Health Status of Individuals with Hemophilia A and B

     

    AUTORES Tyler W. Buckner, MD, MSc1; Shannon L Carpenter, MD2; Stacy E. Croteau, MD3; Adam Cuker, MD, MS4; Nabil Daoud, MA5;Christine L Kempton, MD, MSc6; Lynn M Malec, MD7; Thomas W. McLean, MD8; Leslie J. Raffini, MD9; Janice M Staber, MD10; Michael Wang, MD11, Crystal Watson, BS5; Ayesha Zia12 and Michael Recht, MD, PhD5,13
    .
    1Divisions of Hematology and Pediatric Hematology/Oncology, Hemophilia and Thrombosis Center, University of Colorado School of Medicine, Aurora, CO; 2Children’s Mercy Hospital, Kansas City, MO; 3Children’s Hospital Boston, Boston, MA; 4Department of Medicine and Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA; 5American Thrombosis and Hemostasis Network, Rochester, NY; 6Emory University, Atlanta, GA; 7Blood Research Institute, Versiti, Milwaukee, WI; 8Wake Forest University School of Medicine, Winston Salem, NC; 9Division of Hematology, The Children’s Hospital of Philadelphia, Philadelphia, PA; 10University of Iowa Stead Family Children’s Hospital, Iowa City, IA; 11Anschutz Medical Campus, University of Colorado, School of Medicine, Hemophilia and Thrombosis Center, Aurora, CO; 12University of Southwestern Medical Center, Dallas, TX; 13The Hemophilia Center, Oregon Health and Sci. Univ., Portland, OR.

    Aceda ao Abstract

    861 Real-World Clinical and Laboratory Characteristics in Severe Hemophilia a Patients Commencing Emicizumab

    AUTORES Gavin Ling, MBBS, FRCPath, PhD1; Aderonke Ajidahun, RN2; Steve K. Austin, BMedSci, MBBS2; Gerard Dolan, MBChB, FRCP, FRCPath2; Aine McCormick, PhD2.

    1Department of Haematology, Guy’s & St Thomas’ NHS Foundation Trust, London, Eng, United Kingdom, 2Haemostasis and Thrombosis Centre, Guy’s and St Thomas’ NHS Foundation Trust, London, United Kingdom.

    Aceda ao Abstract
    Online Session

    866 Real-World Persistence with and Adherence to Emicizumab Prophylaxis in Persons with Hemophilia a: A Secondary Claims Database Analysis

    AUTORES Arash Mahajerin1; Rahul Khairnar2; Craig S. Meyer2; Ibrahim M. Abbass2; Rongrong Wang2; Lucy Lee2; Eunice Tzeng2; Karina Raimundo2
    .
    1CHOC Children’s Hospital, Orange, CA; 2Genentech, Inc., South San Francisco, CA.

    Aceda ao Abstract
    Online Session

    868 Inhibit Clinical Trials Platform to Prevent and Eradicate Inhibitors: Feasibility Survey of Current Prophylaxis and Immune Tolerance Practices


    AUTORES Margaret V. Ragni, MD, MPH1; Frederico Xavier, MD, MS2; Craig D. Seaman3; Suchitra Acharya, MD4; Catherine E. McGuinn, MD5; Eric J. Werner, MD6; Courtney Elizabeth Lawrence, MD, MS7; Allison P. Wheeler, MD8; Ulrike Reiss, MD9; Irmel Ayala, MD10; Erin Cockrell, DO11; Cristina Tarango, MD12; Amy Dunn13; Roshni Kulkarni, MD14; Sanjay P Ahuja, MD15; Meera B. Chitlur, MD16; Steven W. Pipe, MD17; Lynn M Malec, MD18; Vilmarie Rodriguez, MD19; Shelley Crary, MD, MS20; Deborah Brown, MD21; Rosa Diaz, MD22; Maria Velez, MD23; Cindy A. Leissinger, MD24; Shannon L Carpenter, MD25; Christine M. Knoll, MD26; Michael Wang, MD27; Guy Young, MD28; Courtney D ThornburgMD29 ; Joseph L Lasky III, MD30; Tiffany Lin Lucas, MD31; Nina Hwang, MD32; Deborah Vehec, MSN, RN33; Dana Ivanco34; Tamara L. Haller, BS35; Marnie Bertolet, PhD36; Maria M Brooks, PhD37

    1University of Pittsburgh Medicine, Division Hematology/Oncology, Pittsburgh, PA; 2Children’s Hospital of Pittsburgh, University of Pittsburgh Medical Center and Hemophilia Center of Western PA,Pittsburgh, PA; 3University of Pittsburgh, Warrendale, PA; 4Pediatric Hematology, Oncology and Cellular Therapy, Cohen Children’s Medical Center of New York, New Hyde Park, NY; 5Weill Cornell Medical College, New York, NY; 6Children’s Hospital of The King’s Daughters, Norfolk, VA; 7Division of Pediatric Hematology / Transfusion Medicine, Johns Hopkins University School of Medicine, Baltimore, MD; 8Dept. of Pediatric Hem./Onc., Monroe Carell Jr. Children’s Hospital at Vanderbilt, Nashville, TN; 9Department of Surgery, St. Jude Children’s Rsch. Hosp., Memphis, TN; 10Pediatric Cancer and BloodDisorders Center, Johns Hopkins All Children’s Outpatient Care Center, St. Petersburg, FL; 11St. Joseph’s Children’s Hospital, Tampa, FL; 12Division of Hematology, Cancer and Blood Diseases Institute, Cincinnati Children ’s Hospital Medical Center, Cincinnati, OH; 13Nationwide Children’s Hospital, Columbus, OH; 14Michigan State University Center for Bleeding and Clotting Disorders, East Lansing, MI; 15University Hospitals Cleveland Medical Center, Rainbow Babies and Children’s Hospital, Cleveland, OH; 16Hemostasis and Thrombosis Center, Children’s Hospital of Michigan, Detroit, MI; 17Departments of Pediatrics and Pathology, University of Michigan, Ann Arbor, MI; 18Blood Research Institute, Versiti, Milwaukee, WI; 19Division of Pediatric Hematology, Mayo Clinic, Rochester, MN; 20University of Arkansas for Medical Sciences, Little Rock, AR; 21Department of Pediatrics- Hematology Division, University of Texas Health Science Center at Houston, Houston, TX; 22Texas Children’s Hospital, Houston, TX; 23Children’s Hospital New Orleans, Louisiana State University, New Orleans, LA; 24Tulane University, New Orleans, LA; 25Children’s Mercy Hospital, Kansas City, MO; 26Arizona Hemophilia and Thrombosis Center, Phoenix Children’s Hospital, Phoenix, AZ; 27Anschutz Medical Campus, University of Colorado, School of Medicine, Hemophilia and Thrombosis Center, Aurora, CO; 28University of Califormia Los Angeles, Children’s Hospital Los Angeles, Los Angeles, CA; 29Rady Children’s Hospital, San Diego, CA; 30University of Nevada, Cure 4 the Kids Foundation, Las Vegas, NV; 31University of California, San Francisco, San Francisco, CA; 32CHOC Children’s Hospital, Orange County, Center for Inherited Blood Disorders (CIBD), Orange, CA; 33Hemophilia Center of Western PA, Institute for Transfusion Medicine, Vitalant, Pittsburgh, PA; 34Institute for Transfusion Medicine, Hemophilia Center of Western PA, Pittsburgh, PA; 35Department of Epidemiology, Epidemiology Data Center, University of Pittsburgh, Pittsburgh, PA; 36Epidemiology Data Center, University of Pittsburgh, Pittsburgh, PA; 37Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA.

    Aceda ao Abstract

    1786 A Phase IV, Multicenter, Open-Label Study of Emicizumab Prophylaxis in Persons with Hemophilia a with or without FVIII Inhibitors Undergoing Minor Surgical Procedures


    AUTORES Midori Shima, MD1; Sayaka Nagami, BSc2; Koichiro Yoneyama, MSc2; Akira Nomura, MSc2; Yoshiyuki Ogawa, MD, PhD3; Kagehiro Amano, MD, PhD4; Keiji Nogami, MD, PhD5.

    1Thrombosis and Hemostasis Research Center, Nara Medical University, Kashihara, Japan; 2Chugai Pharmaceutical Co., Ltd., Tokyo, Japan; 3Department of Hematology, Gunma University Graduate School of Medicine, Maebashi, Japan; 4Department of Laboratory Medicine, Tokyo Medical University, Tokyo, Japan; 5Department of Pediatrics, Nara Medical University, Kashihara, Japan.

    Aceda ao Abstract
    Online Session

    1787 Real-World Clinical Outcomes in Previously Untreated and Minimally Treated Patients with Congenital Factor VIII Deficiency: The San Diego Experience


    AUTORES Kelly A Bush, MD1,2; Hilda Ding, MD, MS1,2; Kate O’Flaherty-Keese, RN, MSN, CPNP1; Rosalie Brooks, RN1; Katharine Farrow, RN, BSN1; Jovanee Recendez, MPH1; Jacqueline Limjoco, RN1; Courtney D Thornburg, MD1,2.

    1Hemophilia and Thrombosis Treatment Center, Rady Children’s Hospital San Diego, San Diego, CA; 2Department of Pediatrics, Division of Hematology/Oncology, UC San Diego School of Medicine, La Jolla, CA.

    Aceda ao Abstract

    1791 Real-World Experience Using Emicizumab Prophylaxis for Hemophilia a: Single-Center Experience


    AUTORES Anshul Vagrecha, MBBS1; Joseph Stanco, RN CRA1; Daphenee Ulus, FNP1; Suchitra Acharya, MD2.

    1Pediatric Hematology, Oncology and Cellular Therapy, Cohen Children’s Medical Center, New Hyde Park, NY; 2Pediatric Hematology, Oncology and Cellular Therapy, Cohen Children’s Medical Center of
    New York, New Hyde Park, NY.

    Aceda ao Abstract
    Online Session

    1793 Analysis of Hemophilia a Outcomes and Treatment Patterns Using Real-World Data from the Canadian Hemophilia Bleeding Disorder Registry


    AUTORES Adrienne Lee, MD1; Federico Germini, MD, MSc2; Man-Chiu Poon, MD3; Arun Keepanasseril2; Quazi Ibrahim, MSc2; Aijing Shang,MD, PhD4; Francis Nissen4; Oliver Meier4; Cami S. Sima, MD5; Davide Matino2; Alfonso Iorio, MD, PhD6,7.

    1Department of Medicine, Cumming School of Medicine University of Calgary, Calgary, AB, Canada; 2Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada; 3University of Calgary Cumming School of Medicine, Alberta, Canada; 4F. Hoffmann-La Roche Ltd, Basel, Switzerland; 5Genentech, Inc., South San Francisco, CA; 6Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Canada; 7McMaster-Bayer Endowed Research Chair in Clinical Epidemiology of Congenital bleeding Disorders, Department of Medicine, McMaster University, Hamilton, Canada.

    Aceda ao Abstract

    1800 Safety and Efficacy of Emicizumab in Persons with Hemophilia a with or without FVIII Inhibitors: Pooled Data from Four Phase III Studies (HAVEN 1–4)


    AUTORES Michael U. Callaghan, MD1; Claude Négrier2; Ido Paz-Priel, MD3; Tiffany Chang3; Sammy Chebon4; Michaela Lehle4; Johnny Mahlangu5; Guy Young, MD6; Rebecca Kruse-Jarres, MD7; Maria Elisa Mancuso8, Markus Niggli4; Peter Kuebler3; Nives Selak Bienz4; Midori Shima, MD9; Victor Jimenez-Yuste, Medical Degree. PhD10; Christophe Schmitt4; Elina Asikanius4; Gallia Levy3; Steven W. Pipe, MD11; Johannes Oldenburg12.

    1Children’s Hospital of Michigan, Detroit, MI; 2Edouard Herriot University Hospital, Lyon, France; 3Genentech, Inc., South San Francisco, CA; 4F. Hoffmann-La Roche Ltd, Basel, Switzerland; 5University of the Witwatersrand and NHLS, Johannesburg, South Africa; 6University of Southern California Keck School of Medicine, Children’s Hospital Los Angeles, Los Angeles, CA; 7BloodWorks NorthWest, Seattle, WA; 8Angelo Bianchi Bonomi Haemophilia and Thrombosis Center, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milano, Italy; 9Nara Medical University Hospital, Kashihara, Japan; 10Hospital Universitario La Paz, Autonoma University, Madrid, Spain; 11University of Michigan, Ann Arbor, MI; 12University of Bonn, Bonn, Germany.

    Aceda ao Abstract
    Online Session

    2532 Problem Joints and Their Clinical and Humanistic Burden in Children and Adults with Moderate and Severe Hemophilia a: CHESS Paediatrics and CHESS II


    AUTORES Paul McLaughlin, MSc, MMACP1; Cedric Hermans, MD, MRCP, PhD2; Sohaib Asghar, MSc3; Tom Burke3; Francis Nissen4; Martynas Aizenas5; Oliver Meier4; Harpal Dhillon3; Jamie O’Hara, MSc3,6.

    1Katharine Dormandy Haemophilia Centre and Thrombosis Unit, Royal Free London NHS Foundation Trust, London, United Kingdom; 2Division of Hematology, Cliniques Univ. Saint-Luc, Brussels, Belgium; 3HCD Economics, Daresbury, United Kingdom; 4F. Hoffmann-La Roche Ltd, Basel, Switzerland; 5F. Hoffmann-La Roche Ltd, Basel, CA, Switzerland; 6University of Chester, Chester, United Kingdom.

    Aceda ao Abstract
    Online Session

    2685 Real-World Safety of Emicizumab: The First Interim Analysis of the European Haemophilia Safety Surveillance (EUHASS) Database


    AUTORES Aijing Shang, MD, PhD1; Nives Selak Bienz1; Ravi Gadiraju1; Tiffany Chang2; Peter Kuebler2.

    1F. Hoffmann-La Roche Ltd, Basel, Switzerland; 2Genentech, Inc., South San Francisco, CA.

    Aceda ao Abstract
    Online Session

    2697 In Vitro Evaluation of Thrombin Generation of Eptacog Beta (Factor VIIa, Recombinant) and Emicizumab in Congenital Hemophilia Α Plasma with and without Inhibitors


    AUTORES Steven W. Pipe, MD1; Michael Recht, MD, PhD2; Michael U. Callaghan, MD3; Robert F. Sidonio Jr., MD, MSc.4; Jerry Grandoni, PhD5; Veronique Duretz6; Daniel Bonzo, PhD5; Jean Luc Plantier, PhD7; Sean Evans, PhD, RPh5; Ian S Mitchell, PhD8; Cedric Hermans, MD, MRCP, PhD9.

    1Departments of Pediatrics and Pathology, University of Michigan, Ann Arbor, MI; 2American Thrombosis and Hemostasis Network, Rochester, NY; 3Children’s Hospital of Michigan, Detroit, MI; 4Aflac Cancer and Blood Disorders and Emory University, Atlanta, GA; 5LFB, Framingham, MA; 6LFB, Lille, France; 7LFB, Loos, France; 8GLOVAL, LLC, Lafayette, CO; 9Cliniques Univ. Saint-Luc, Brussels, Belgium.

    Aceda ao Abstract
    Online Session

    3449 An Insight into the Impact of Hemophilia a on Daily Life According to Disease Severity: A Preliminary Analysis of the CHESS II Study


    AUTORES Declan Noone, MSc1; Francis Nissen2; Tao Xu2; Tom Burke1; Sohaib Asghar, MSc1; Harpal Dhillon1; Martynas Aizenas2; Oliver Meier2; Jamie O’Hara, MSc1,3; Kate Khair, PhD4.

    1HCD Economics, Daresbury, United Kingdom; 2F. Hoffmann-La Roche Ltd, Basel, Switzerland; 3University of Chester, Chester, United Kingdom; 4Haemnet, London, United Kingdom.

    Aceda ao Abstract
    Online Session

    3457 Impact of Hemophilia a Inhibitor on Joint Health and Health-Related Quality of Life from the Hemophilia Utilization Group Studies Part VIII in the U.S


    AUTORES Megan M. Ullman, MA, MPH1; Marilyn J Manco-Johnson, MD2; Jonathan C. Roberts, MD3; Nicole Crook, RN4; Rahul Khairnar5; Joanne Wu, MD, MS6; Steven Carrasco, MPH7; Randall Curtis, MBA8; Judith Baker, DrPH, MHSA4; Duc Quang Tran Jr., MD9; Michael B. Nichol, PhD7.

    1Gulf States Hemophilia & Thrombophilia Center, University of Texas Health Science Center at Houston, Houston, TX; 2University of Colorado Anschutz Medical Campus, Aurora, CO; 3Bleeding & Clotting Disorders Institute, Peoria, IL; 4Center for Inherited Blood Disorders, Orange, CA; 5Genentech, Inc., South San Francisco, CA; 6University Of Southern California, Los Angeles, CA; 7University of Southern California, Los Angeles, CA; 8Factor VIII Computing, Berkeley, CA; 9Emory University, Hemophilia of Georgia Center for Bleeding & Clotting Disorders of Emory, Atlanta, GA.

    Aceda ao Abstract

    "Roche"

    RocheNet

    A sua sessão na RocheNet vai expirar. Quer continuar?

    SIM NÃO
    • © 2023 Roche Portugal
    • 11.01.2022
    • Termos Legais
    • Política de Privacidade
    • Cookie settings

    • Encontre-nos no Twitter
    • Encontre-nos no Linkedin
    • Encontre-nos no Facebook
    • Encontre-nos no Youtube